Apex Healthcare in JV agreement

KUALA LUMPUR: Apex Healthcare Bhd’s Singapore subsidiary First SGC Pte Ltd has subscribed for a 40% stake in a joint venture (JV) company with Shanghai Pharmaceutical Import & Export Co Ltd for S$1.2mil (RM3.9mil).

In a filing with Bursa Malaysia, Apex said Shanghai Pharmaceutical would own the remaining 60% of the JV company, which is yet to be incorporated. The move is to commercialise branded pharmaceuticals, consumer healthcare products and medical devices from the SPH and AHB Group under the brand of the JV Co in Asean.